Esrd; Kidney Failure; Pde5i; CVD

  1. madman

    ED Medications in Kidney Failure: PDE5 Inhibitors Linked to Lower Mortality and Heart Risk in ESRD

    Abstract INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED) affects over 70% of men with end-stage renal disease (ESRD), yet the cardiovascular safety of phosphodiesterase type 5 inhibitors (PDE5i) in this population remains poorly understood. Concerns persist due to altered...

Esrd; Kidney Failure; Pde5i; CVD

Esrd; Kidney Failure; Pde5i; CVD

Beyond Testosterone Podcast

Back
Top